lactic acid has been researched along with trimethoprim, sulfamethoxazole drug combination in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amaral, AC; Bocca, AL; Felipe, MS; Marques, AF; Morais, PC; Muñoz, JE; Simioni, AR; Taborda, CP; Tedesco, AC; Travassos, LR | 1 |
1 other study(ies) available for lactic acid and trimethoprim, sulfamethoxazole drug combination
Article | Year |
---|---|
Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis.
Topics: Animals; Anti-Infective Agents; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Therapy, Combination; Freund's Adjuvant; Glycoproteins; Immunologic Factors; Lactic Acid; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Paracoccidioides; Paracoccidioidomycosis; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |